Rani Therapeutics Holdings, Inc.
NASDAQ:RANIBiotechnology
-$0.04 today
- Market cap
- $52.19M
- Beta
- 0.76
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$0.16
Volume 0.23M
Average 1.15M
Balance Sheet
Inspect the capital base behind the business.
Assets
$58.62M
FY 2025 · Annual
+60.0% YoYLiabilities
$17.11M
FY 2025 · Annual
-48.4% YoYEquity
$41.51M
FY 2025 · Annual
+1088.4% YoYBalance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 117.45M | 27.01M | 5.86M | 3.76M | 18.62M |
| Short-term Investments | 0 | 71.48M | 42.68M | 23.88M | 31.09M |
| Net Receivables | 0 | 0 | 200K | 428K | 2.04M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 500K | 800K | 1.68M | 1.57M |
| Total Current Assets | 119.6M | 100.92M | 50.85M | 29.74M | 53.32M |
| Property, Plant & Equipment (Net) | 4.61M | 7.1M | 6.82M | 6.64M | 5.05M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 246K | 246K | 246K |
| Total Non-current Assets | 4.61M | 7.1M | 7.07M | 6.89M | 5.3M |
| Total Assets | 124.21M | 108.03M | 57.92M | 36.63M | 58.62M |
| Account Payables | 1.08M | 1.46M | 648K | 1.36M | 309K |
| Short-term Debt | 0 | 0 | 4.9M | 15M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 1.21M | 0 | 6.83M |
| Other Current Liabilities | 398K | 591K | 202K | 283K | 46K |
| Total Current Liabilities | 2.64M | 4.82M | 7.99M | 19.89M | 12.67M |
| Long-term Debt | 0 | 29.15M | 24.48M | 9.61M | 2.73M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 1.71M |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 29.21M | 24.48M | 13.25M | 4.44M |
| Total Liabilities | 2.64M | 34.02M | 32.47M | 33.14M | 17.11M |
| Common Stock | 5K | 5K | 5K | 5K | 11K |
| Retained Earnings | (8.33M) | (38.92M) | (72.89M) | (102.91M) | (132.58M) |
| Accumulated OCI | (0) | (73K) | (12K) | 5K | 1K |
| Other Stockholders Equity | (2) | 0 | 0 | 0 | 0 |
| Minority Interest | 74.16M | 37.15M | 12.58M | 1.5M | 8.5M |
| Total Equity | 121.57M | 74M | 25.44M | 3.49M | 41.51M |
| Total Debt | 0 | 30.21M | 30.1M | 29.71M | 4.32M |
| Net Debt | (117.45M) | 3.21M | 24.24M | 25.95M | (14.3M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $9.6M |
| Short-term Investments | $33.8M |
| Receivables | $2.1M |
| Other Current | $1.6M |
| Total Current Assets | $47.1M |
| PP&E (Net) | $4.5M |
| Other Non-current | $246.0K |
| Total Non-current Assets | $4.8M |
| Total Assets | $51.9M |
Analysis
Selected assets total $51.9M for Latest. The largest visible component is Short-term Investments at $33.8M, about 65.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Sep 29, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 29, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 | |
| 10-Q | Quarterly report | Aug 13, 2026 | |
| 8-K | Current report | Aug 13, 2026 |
How much cash does RANI have?
Rani Therapeutics Holdings, Inc. (RANI) reported $18.62M in cash and equivalents in fiscal 2025.
How much debt does RANI carry?
Rani Therapeutics Holdings, Inc. (RANI) reported $4.32M of total debt, with net debt of -$14.30M.
Continue the stock analysis
Jump to another research area for this company.